☆ 4.8 Article

International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance

JOURNAL OF HEPATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Risk factors for HCC in contemporary cohorts of patients with cirrhosis

Fasiha Kanwal et al.

Summary: This study investigated the risk of developing HCC in patients with cirrhosis and found that the incidence rate of HCC was lower than previously reported. The risk of HCC varied depending on the etiology, with higher risk in patients with cured HCV and lower risk in those with NAFLD. Current smoking and overweight/obesity were also associated with increased HCC risk.

HEPATOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma

Takeshi Yokoo et al.

Summary: This study evaluated the sensitivity and specificity of dynamic contrast-enhanced abbreviated MRI for the detection of early-stage hepatocellular carcinoma (HCC). The results showed that dynamic abbreviated MRI had high sensitivity and specificity in detecting early-stage HCC in patients with compensated cirrhosis, but lower sensitivity in those with decompensated cirrhosis.

RADIOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Risk stratification and early detection biomarkers for precision HCC screening

Yi-Te Lee et al.

Summary: Hepatocellular carcinoma (HCC) mortality remains high due to late diagnosis, but traditional screening approaches may not be practical in the face of shifting disease etiologies. New modalities and strategies are urgently needed to improve early HCC detection.

HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

Amit G. Singal et al.

HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

Neehar D. Parikh et al.

Summary: Hepatocellular carcinoma (HCC) is a major contributor to cancer-related deaths globally due to inadequate early detection strategies. Current screening recommendations have several deficiencies, including suboptimal sensitivity and poor adherence. Blood-based biomarkers show promise but require validation and logistical solutions before clinical implementation. Maturing validation cohorts, such as the Hepatocellular Carcinoma Early Detection Study and the Texas Hepatocellular Carcinoma Consortium, are expected to provide robust validation for candidate biomarkers.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States

Nicole J. Kim et al.

Summary: The survey found that the majority of providers support semi-annual HCC surveillance, with a preference for ultrasound combined with alpha fetoprotein testing. Barriers to surveillance include limited treatment options, screening test effectiveness, transportation access, and high costs.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

Amit G. Singal et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis with survival rates below 20% in 5 years, partly due to failures in the cancer screening process continuum. A conceptual model outlining discrete steps in the HCC screening process highlights delays or failures at each step and identifies factors contributing to these failures at the patient, provider, and health care system levels. Comparing HCC screening processes with breast and colorectal cancer screening can help identify opportunities for improvement and ultimately improve early detection of HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study

Nicolas Chong et al.

Summary: This study found that impaired ultrasound visualization is associated with worse surveillance test performance in patients with cirrhosis. Severe visual limitations were linked to lower sensitivity, while moderate limitations were associated with an increased risk of false-positive results. Alternative blood-based biomarkers and imaging strategies are needed for patients at risk of ultrasound-based surveillance failure.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations

David T. Fetzer et al.

Summary: This study identified patient location and sonographer volume as important factors influencing the visualization score of liver ultrasound in HCC screening, which is significant for guiding targeted quality improvement efforts and establishing best practices and performance standards for screening programs.

AMERICAN JOURNAL OF ROENTGENOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression

Lorenzo A. Orci et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for hepatocellular carcinoma (HCC), and this study used meta-analysis to analyze the incidence rates of HCC in NAFLD patients. The results showed that NAFLD patients with cirrhosis have a similar risk of developing HCC compared to cirrhosis patients with other causes. However, the incidence of HCC in nonalcoholic steatohepatitis or simple steatosis patients is lower.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance

Amit G. Singal et al.

Summary: Mailed outreach for HCC surveillance significantly increased semiannual surveillance and improved proportion of time covered by surveillance in patients with cirrhosis. The intervention effect was consistent across most examined subgroups. Continued follow-up is needed to assess the impact on downstream outcomes.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

Amit G. Singal et al.

Summary: Evaluation of the biomarker GALAD for early detection of HCC in a cohort of patients with cirrhosis demonstrates high sensitivity.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Amit G. Singal et al.

Summary: In this systematic review and meta-analysis, HCC surveillance was found to be associated with improved early-stage detection, curative treatment receipt, and survival in patients with cirrhosis. However, there was significant heterogeneity in the pooled estimates, and there were fewer data quantifying potential surveillance-related harms. Available data suggest that HCC surveillance is of high value in patients with cirrhosis, although further studies evaluating benefits and harms are still needed.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Georg Semmler et al.

Summary: The study developed risk stratification algorithms for de novo HCC development after SVR in patients with ACLD. Parameters such as post-treatment AFP, alcohol consumption, age, LSM, and albumin accurately predicted de novo HCC development and stratified patients into low- and high-risk groups. These algorithms identified approximately two-thirds of patients with cACLD as having a low risk of <1%/year for HCC development, showing effectiveness in risk assessment and surveillance.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients

Hyo Jung Park et al.

Summary: By comparing the performance of gadoxetic acid-enhanced abbreviated MRI (AMRI)-based surveillance and ultrasound-only surveillance in high-risk patients for hepatocellular carcinoma (HCC), it was found that AMRI-based surveillance had higher sensitivities and accuracies for early-stage HCC than ultrasound-only surveillance.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Haley Schoenberger et al.

Summary: Nearly 1 in 5 patients with cirrhosis had moderately-severely limited ultrasound visualization for HCC nodules, particularly those with obesity or alcohol-related or nonalcoholic fatty liver disease cirrhosis. Ultrasound quality can change between exams, including improvement in many patients with limited visualization.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma

Naga P. Chalasani et al.

Summary: The study found that multitarget HCC blood test may significantly improve early stage HCC detection, providing more treatment opportunities for patients and reducing mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Editorial Material Oncology

Multicancer Early Detection: Learning From the Past to Meet the Future

Ruth Etzioni et al.

Summary: This article discusses the potential impact of multicancer early detection tests and highlights three key factors that influence the balance of benefits and harms in early detection testing, namely the ability to confirm cancer signals, population testing strategies, and the natural history of targeted cancers. It emphasizes the critical gaps in current knowledge that hinder accurate predictions of the clinical impact of MCED testing.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

添加到收藏夹

Article Cell Biology

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

Daniel Q. Huang et al.

Summary: Liver cancer epidemiology is changing due to factors such as increasing alcohol consumption, rising obesity rates, and advancements in hepatitis B and C treatment. The Global Burden of Disease study estimated global and regional trends in liver cancer burden, revealing a 25% increase in liver cancer deaths between 2010 and 2019. Non-alcoholic steatohepatitis (NASH) and alcohol were found to have the fastest growing death rates, while hepatitis B and C showed declines. Urgent measures are needed globally to address metabolic risk factors and slow the growing burden of NASH-associated liver cancer, particularly in the Americas.

CELL METABOLISM (2022)

添加到收藏夹

Article Cell Biology

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Naoto Fujiwara et al.

Summary: This study analyzed multiple cohorts of NAFLD patients globally to define and validate signatures predictive of long-term HCC risk in NAFLD patients. These signatures can accurately predict the risk of developing HCC in patients and provide assistance for clinical treatment.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma

Nan Lin et al.

Summary: This study demonstrates that the HelioLiver Test has superior performance in detecting early hepatocellular carcinoma compared to the guideline-recommended ultrasound and serum AFP tests. The test combines cell-free DNA methylation patterns, clinical variables, and protein tumor markers.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis

Erin Wolf et al.

Summary: The study found that HCC surveillance is underused in clinical practice, especially among patients with alcohol-associated or NASH-related cirrhosis and those not followed in subspecialty gastroenterology clinics. Interventions such as provider education, inreach including reminder systems, and population health outreach efforts can significantly increase HCC surveillance.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: The study found that patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation significantly impact less frequent receipt of HCC surveillance. This indicates a need for patient-centered interventions, such as patient navigation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: In a cohort of patients with cirrhosis, HCC surveillance was associated with high early tumor detection and minimal physical harms.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Amit G. Singal et al.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis

Pankaj Gupta et al.

Summary: Abbreviated MRI (AMRI) is suggested as an alternative for hepatocellular carcinoma (HCC) screening. Our study showed that AMRI has high sensitivity and specificity for HCC screening. Different AMRI protocols have comparable diagnostic performance.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

Cristiana Bianco et al.

Summary: This study utilized polygenic risk scores (PRS) to investigate the causal relationship between hepatic fat and HCC, improving the accuracy of HCC detection and helping to stratify HCC risk in individuals with dysmetabolism. The PRS showed robust predictions for HCC in both high-risk individuals and the general population.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review: Radiomics for the diagnosis and prognosis of hepatocellular carcinoma

Emily Harding-Theobald et al.

Summary: Studies have shown that radiomic features have good discriminatory performance in differentiating HCC from other solid lesions, predicting microvascular invasion, early recurrence after hepatectomy, and prognosis after therapies. However, the overall quality of the included studies was low due to common deficiencies in internal and external validation, standardized imaging segmentation, and comparison to a gold standard. Therefore, standardization of protocols and outcome measurements, sharing of algorithms and analytic methods, and external validation are necessary before widespread application of radiomics in HCC diagnosis and prognosis in clinical practice.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms

Neehar D. Parikh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Article Oncology

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M. C. Liu et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma

Jinping Liu et al.

CELL (2020)

添加到收藏夹

Article Oncology

A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development

Jeong Hee Yoon et al.

LIVER CANCER (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status

Etienne Audureau et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis

George N. Ioannou et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance

Okeefe L. Simmons et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy

Chunfeng Qu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification

George N. Ioannou et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Amit G. Singal et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network

Kelly A. Borges et al.

CONTEMPORARY CLINICAL TRIALS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study

Ziding Feng et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Kristina Tzartzeva et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Review Chemistry, Multidisciplinary

Technical challenges of working with extracellular vesicles

Marcel I. Ramirez et al.

NANOSCALE (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Jonathan G. Stine et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Oncology

Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial

Chansik An et al.

BMC CANCER (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C

George N. Ioannou et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease

Fasiha Kanwal et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis

O. Simmons et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis

Omair Atiq et al.

HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

Nicolas Goossens et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

添加到收藏夹

Article Oncology

MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma

So Yeon Kim et al.

JAMA ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol

Hyun A. Kim et al.

BMC CANCER (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Sarah Berhane et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Improved Surveillance for Hepatocellular Carcinoma With a Primary Care-Oriented Clinical Reminder

Lauren A. Beste et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

Alessandro Cucchetti et al.

JOURNAL OF HEPATOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

Amit G. Singal et al.

PLOS MEDICINE (2014)

添加到收藏夹

Review Gastroenterology & Hepatology

A Primer on Effectiveness and Efficacy Trials

Amit G. Singal et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?

Amit G. Singal et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12 134 examinations (Berlin colonoscopy project 3, BECOP-3)

Andreas Adler et al.

GUT (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Feasibility of Conducting a Randomized Control Trial for Liver Cancer Screening: Is a Randomized Controlled Trial for Liver Cancer Screening Feasible or Still Needed?

Hossein Poustchi et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis

Karin L. Andersson et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

添加到收藏夹

Article Oncology

Randomized controlled trial of screening for hepatocellular carcinoma

BH Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.